144 related articles for article (PubMed ID: 9261037)
1. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia in the diabetic kidney is independent of advanced glycation end-products.
Nordquist L; Liss P; Fasching A; Hansell P; Palm F
Adv Exp Med Biol; 2013; 765():185-193. PubMed ID: 22879032
[TBL] [Abstract][Full Text] [Related]
3. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G
Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295
[TBL] [Abstract][Full Text] [Related]
4. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
7. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
[TBL] [Abstract][Full Text] [Related]
8. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
Cameron NE; Cotter MA
Metabolism; 1996 Sep; 45(9):1147-52. PubMed ID: 8781303
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy.
Bach LA; Dean R; Youssef S; Cooper ME
Nephrol Dial Transplant; 2000 Mar; 15(3):347-54. PubMed ID: 10692520
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
11. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.
Youssef S; Nguyen DT; Soulis T; Panagiotopoulos S; Jerums G; Cooper ME
Kidney Int; 1999 Mar; 55(3):907-16. PubMed ID: 10027927
[TBL] [Abstract][Full Text] [Related]
12. Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue.
Hu C; Cong XD; Dai DZ; Zhang Y; Zhang GL; Dai Y
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):309-19. PubMed ID: 21267711
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats.
Usta MF; Bivalacqua TJ; Yang DY; Ramanitharan A; Sell DR; Viswanathan A; Monnier VM; Hellstrom WJ
J Urol; 2003 Oct; 170(4 Pt 1):1437-42. PubMed ID: 14501785
[TBL] [Abstract][Full Text] [Related]
15. Effects of aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats.
Li Q; Ao X; Du Y; Li Y; Ou Y; Gong R; Sun X; Yang YX; Wen G
Endocrine; 2011 Jun; 39(3):251-8. PubMed ID: 21086190
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.
Forbes JM; Cooper ME; Thallas V; Burns WC; Thomas MC; Brammar GC; Lee F; Grant SL; Burrell LM; Jerums G; Osicka TM
Diabetes; 2002 Nov; 51(11):3274-82. PubMed ID: 12401719
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
Usta MF; Bivalacqua TJ; Koksal IT; Toptas B; Surmen S; Hellstrom WJ
BJU Int; 2004 Aug; 94(3):429-32. PubMed ID: 15291881
[TBL] [Abstract][Full Text] [Related]
18. Pimagedine: a novel therapy for diabetic nephropathy.
Abdel-Rahman E; Bolton WK
Expert Opin Investig Drugs; 2002 Apr; 11(4):565-74. PubMed ID: 11922864
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.
Osicka TM; Yu Y; Lee V; Panagiotopoulos S; Kemp BE; Jerums G
Clin Sci (Lond); 2001 Mar; 100(3):249-57. PubMed ID: 11222110
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
Yamabe N; Kang KS; Goto E; Tanaka T; Yokozawa T
Biol Pharm Bull; 2007 Mar; 30(3):520-6. PubMed ID: 17329849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
